NCT01205269 - The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

AZD8683, 50 mcg

Dry powder for inhalation, single dose

DRUG

Placebo

Dry powder for inhalation, single dose

DRUG

AZD8683, 200 mcg

Dry powder for inhalation, single dose

Trial Locations (4)

Research Site, Bialystok

Research Site, Bydgoszcz

Research Site, Lodz

Research Site, Proszowice